ngµç×ÓÓÎÏ·ÐÂÎÅÍøѶ£¨Í¨Ñ¶Ô±Àµ¤£©2023Äê6ÔÂ10ÈÕ
£¬£¬£¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÐìÈ𻪽ÌÊÚ¡¢¡¢ÕÅÏþʵ½ÌÊÚÍŶÓÔÚNature communicationsÉÏÔÚÏß½ÒÏþÌâΪ¡°Ò»Ïî¹ØÓÚÍâÖÜѪµ¥¸öºËϸ°ûȪԴµÄп¹Ô­ÌØÒìÐÔCD8⁺Tϸ°ûÖÎÁÆÍíÆÚʵÌåÁö»¼ÕßÇåÁÜÇ¿¶ÈµÄÆðÔ´Ñо¿¡±¡£¡£¡£¸ÃÑо¿ÊÇÒ»Ïî̽ÌÖп¹Ô­ÌØÒìÐÔCD8⁺Tϸ°û£¨Neo-T£©ÖÎÁƱê×¼ÖÎÁÆÄÑÖÎÐÔ¾Ö²¿ÍíÆÚ»òתÒÆÐÔʵÌåÁöµÄÇåÁÜ·½°¸µÄµ¥±Û¡¢¡¢¿ª·Å¡¢¡¢·ÇËæ»ú¢ñÆÚÑо¿¡£¡£¡£Ñо¿Ð§¹ûÏÔʾ
£¬£¬£¬ÎÞÇåÁÜÔ¤´¦ÀíµÄNeo-TÁÆ·¨¿ÉÄÜÊÇÖÎÁÆÍíÆÚʵÌåÁöµÄÒ»ÖÖÇå¾²¡¢¡¢ÓÐÔ¶¾°ÖÎÁÆ·½°¸¡£¡£¡£

¹ý¼ÌÐÔTϸ°ûÁÆ·¨£¨adoptive T cell therapy
£¬£¬£¬ACT£©ÕýÔÚ³ÉΪÍíÆÚÖ×Áö»¼ÕßÓÐÔ¶¾°µÄÖÎÁÆÑ¡Ôñ¡£¡£¡£ÕâЩ¹ý¼Ìϸ°û°üÀ¨Ç¶ºÏ¿¹Ô­ÊÜÌ壨CAR£© T ϸ°û¡¢¡¢T ϸ°ûÊÜÌ壨TCR£©T ϸ°ûºÍÖ×Áö½þÈóÁÜ°Íϸ°û£¨TIL£©¡£¡£¡£¶àÏîÁÙ´²Ñо¿Åú×¢
£¬£¬£¬Ð¿¹Ô­ÌØÒìÐÔÖ×Áö½þÈóÁÜ°Íϸ°û£¨TIL£©µÄ¹ý¼ÌתÒÆ¿ÉÒԽ鵼¼¸ÖÖʵÌåÖ×ÁöµÄ³¤ÆÚÏûÍË¡£¡£¡£È»¶ø
£¬£¬£¬ÍøÂçTILÐè¶ÔÖ×Áö×éÖ¯¾ÙÐÐÇÖÈëÐÔÈ¡Ñù
£¬£¬£¬ÇÒͨ³£Êܵ½ÇгýÖ×Áö×éÖ¯³ß´çÏà¶Ô½ÏСµÄÏÞÖÆ
£¬£¬£¬±ðµÄ
£¬£¬£¬Ä³Ð©Ö×Áö²¿Î»ÄÑÒÔÈ¡Ñù¡£¡£¡£×î½ü
£¬£¬£¬ÓÐÑо¿±¨µÀ³Æ
£¬£¬£¬ÔÚÖ×Áö»¼ÕßÍâÖÜѪÖз¢Ã÷ÁË¿Éʶ±ðп¹Ô­µÄTϸ°û¿Ë¡¡£¡£¡£²¢ÇÒÍâÖÜѪÁÜ°Íϸ°û£¨peripheral blood lymphocyte
£¬£¬£¬PBL)ÖеÄTϸ°û¿Éʶ±ðп¹Ô­P53
£¬£¬£¬ÓÌÈçTILs¡£¡£¡£Òò´Ë
£¬£¬£¬±¾Ñо¿ÍƲâPBL¿ÉÄܳÉΪ»ñÈ¡Tϸ°ûµÄ¿É¿¿ÇÒÎÞ´´µÄȪԴ
£¬£¬£¬ÓÃÓÚ¿ª·¢°ÐÏòп¹Ô­ACTÁÆ·¨À´ÖÎÁÆÖ×Áö»¼Õß¡£¡£¡£

·ÇÇåËèÐÔÇåÁÜ»¯ÁƳ£ÓÃÓÚACT֮ǰÒÔÒÖÖÆËÞÖ÷ÃâÒßϵͳ
£¬£¬£¬½µµÍÃâÒßÔ­ÐÔ
£¬£¬£¬´Ó¶øÌá¸ßIL2
£¬£¬£¬IL7
£¬£¬£¬IL15µÈµÄ¿ÉÓÃÐÔ
£¬£¬£¬ïÔÌ­µ÷ÀíÐÔTϸ°û£¨Treg£©
£¬£¬£¬²¢ÔöÌí»ØÊäTϸ°ûµÄ³¤ÆÚÐÔ¡£¡£¡£·ú´ïÀ­±õºÍ»·Á×õ£°·ÊÇÇåÁÜ»¯ÁÆ×î³£ÓõÄÒ©Îï¡£¡£¡£È»¶ø
£¬£¬£¬ÇåÁÜÒ²»áÒýÆðÉñ¾­¶¾ÐÔ¡¢¡¢ÖÐÐÔÁ£Ï¸°ûïÔÌ­¡¢¡¢ÑªÐéºÍѬȾ·çÏÕÔöÌíµÈ²»Á¼·´Ó³¡£¡£¡£ÏÖÔÚ
£¬£¬£¬ÇåÁܵĸøÒ©Ç¿¶ÈÔÚ²î±ðµÄÖÐÐĺÍÁÙ´²ÊÔÑéÖвî±ð½Ï´ó
£¬£¬£¬²¢ÇÒÿ¸öTϸ°û²úÆ·¶¼Óи÷×ÔÌØÓеÄÇåÁÜ·½°¸
£¬£¬£¬ÉÐȱ·¦±ê×¼ÇåÁÜ·½°¸¡£¡£¡£

Ñо¿Àú³Ìͼʾ

ÔÚ±¾Ñо¿ÖÐ
£¬£¬£¬Ñо¿Õß¿ª·¢ÁËÒ»ÖÖ´Ó»¼ÕßÍâÖÜѪµ¥ºËϸ°ûÖб¬·¢¸öÐÔ»¯Neo-T£¨Ð¿¹Ô­ÌØÒìÐÔCD8⁺Tϸ°û£©µÄÒªÁì¡£¡£¡£Ê×ÏÈ
£¬£¬£¬½¨ÉèÁËÒ»¸ö¹ÜµÀ
£¬£¬£¬°üÀ¨Í¨¹ýÉúÎïÐÅϢѧÆÊÎö¾ÙÐÐп¹Ô­Ô¤²â
£¬£¬£¬²¢ÔÚ25ÌìÄÚ¶ÔTϸ°û´ó¹æÄ£À©ÔöÌØÒìÐÔп¹Ô­¡£¡£¡£ÎªÁËÆÀ¹ÀNeo-TÖÎÁƵÄÁÙ´²ÁÆЧ²¢È·¶¨Neo-TÖÎÁÆʱµÄ×î¼ÑÇåÁÜÇ¿¶È
£¬£¬£¬Ñо¿ÕßÒÔ·ú´ïÀ­±õºÍ»·Á×õ£°·¼ÁÁ¿µÝÔöµÄ·½Ê½¶ÔNeo-TÁÆ·¨¾ÙÐÐÁËÊ×´ÎÈËÌåÑо¿¡£¡£¡£±¾Ñо¿¹²ÄÉÈëÁË11Àý±ê×¼ÖÎÁÆÄÑÖÎÐÔ¾Ö²¿ÍíÆÚ»òתÒÆÐÔʵÌåÁö»¼Õß
£¬£¬£¬Æ¾Ö¤Èë×éʱ¼ä·ÖΪÈý¸öÖÎÁÆ×飺£º£ºÎÞLD»¯ÁÆÔ¤´¦Àí×é¡¢¡¢µÍÇ¿¶ÈLD»¯ÁÆÔ¤´¦Àí×éºÍ¸ßÇ¿¶ÈLD»¯ÁÆÔ¤´¦Àí×é¡£¡£¡£

Ñо¿Ð§¹ûÏÔʾ
£¬£¬£¬ËùÓÐÈë×黼ÕßµÄPBMC¾ùÀֳɱ¬·¢Neo-T
£¬£¬£¬²¢¿ÉÀÖ³Éʶ±ð¼¸ÖÖÔ¤²âµÄп¹Ô­¡£¡£¡£Ö»¹ÜNeo-TÖÎÁÆÊä×¢¼ÁÁ¿Ïà¶Ô½ÏС£¡£¡£¨4.78E7-9.0E8£©
£¬£¬£¬µ«ÈÔÕ¹ÏÖ³öÓÐÏ£ÍûµÄ¿Í¹Û»º½âÂÊ£¨33%£©
£¬£¬£¬ÓëÊä×¢Tϸ°ûÊýĿΪ1E10-1E11µÄTIL/TCR-TÁÆ·¨ÁÆЧÏ൱¡£¡£¡£³öºõÒâÁϵÄÊÇ
£¬£¬£¬ÎÞÇåÁÜ»¯ÁÆÔ¤´¦Àí×éµÄ»¼ÕßÁÙ´²·´Ó³×î¼Ñ¡£¡£¡£

Èý¸öÖÎÁÆ×éÑо¿Ð§¹û±ÈÕÕ

ÔÚÇå¾²ÐÔ·½Ãæ
£¬£¬£¬×î³£¼ûµÄ²»Á¼·´Ó³°üÀ¨ÑªÐé¡¢¡¢ÁÜ°Íϸ°ûïÔÌ­¡¢¡¢ÂÑ°×Äò¡¢¡¢ðþÑ÷¡¢¡¢Æ¤Õî¡¢¡¢ñ¼ÐÔÐĶ¯¹ýËٵȡ£¡£¡£3-4¼¶²»Á¼·´Ó³¶à±¬·¢ÓÚµÍÇ¿¶ÈLD»¯ÁÆÔ¤´¦Àí×éºÍ¸ßÇ¿¶ÈLD»¯ÁÆÔ¤´¦Àí×é
£¬£¬£¬×î³£¼ûÊÇÁÜ°Íϸ°ûïÔÌ­¡£¡£¡£Î´±¬·¢¼±ÐÔ²»Á¼ÊÂÎñ
£¬£¬£¬×ÜÌå¶øÑÔ
£¬£¬£¬Çå¾²ÐÔÓÅÒì¡£¡£¡£

×ÛÉÏ
£¬£¬£¬±¾Ñо¿Åú×¢
£¬£¬£¬¾­ÓÉÖ×Áö»¼ÕßÍâÖÜѪÖƱ¸¸öÐÔ»¯Neo-T¹ý¼ÌתÒÆÖÎÁÆÀú³ÌÖÐ
£¬£¬£¬²î±ðµÄÇåÁÜ»¯ÁƼÁÁ¿ÄÍÊÜÐÔÓÅÒì
£¬£¬£¬Çå¾²¿É¿Ø¡£¡£¡£²¢ÇÒÔÚÎÞÇåÁÜ»¯ÁÆÔ¤´¦ÀíÇéÐÎÏÂÈÔÄܹ»½éµ¼³¤ÆÚµÄÖ×ÁöÏûÍË¡£¡£¡£

ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÐìÈ𻪽ÌÊÚ¡¢¡¢ÕÅÏþʵ½ÌÊÚÒÔ¼°ÉîÛÚ»ª´ó»ùÒòÑо¿ÔºÕÅêØÑо¿Ô±Îª¸ÃÑо¿ÂÛÎĵÄÅäºÏͨѶ×÷Õß¡£¡£¡£ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÀµ¤¸±Ö÷ÈÎҽʦ¡¢¡¢Àîæºæº¸±Ö÷ÈÎҽʦ¡¢¡¢¶¡æ«¸±Ö÷ÈÎҽʦ¼°ÉîÛÚ»ª´ó»ùÒòÑо¿Ôº³Â³¬¡¢¡¢ÔÀ½¨»Ô¡¢¡¢Íõº£Â×ΪÅäºÏµÚÒ»×÷Õß¡£¡£¡£

ÂÛÎÄÁ´½Ó£º£º£ºhttps://doi.org/10.1038/s41467-023-39225-7